Indeed, in our study, AXIN2 was frequently hypomethylated in MSS cancers, suggesting that the epigenetic change of AXIN2 specifically associates with the MSI pathway for colon cancer. This evidence concerns the gene AXIN2 and malignant colon neoplasm.